Skip to content
The Nexus
DossierENTITY

Jennifer Doudna

Coverage of Jennifer Doudna in the Nexus archive.

Earliest in view: May 13 · 13:13 UTCMost recent: Jul 17 · 14:40 UTC
Co-mentioned in this coverage
GSKorganization1chronic cough treatmenttopic1gene therapytopic1AI-designed gene editorstopic1Kalshiorganization1Biotechtopic1scientific researchtopic1United Statesplace1FDAorganization1STATorganization1San Franciscoplace1STAT Breakthrough West Summittopic1
Recent coverage
  • HEALTHJul 17 · 14:40 UTCSTAT NEWS
    STAT+: The end for GSK’s chronic cough treatment

    The article discusses the end of GSK’s chronic cough treatment and highlights a gene therapy approach generating both excitement and skepticism. It also mentions Jennifer Doudna’s work on AI-designed gene editors and Kalshi’s expansion into biotech.

  • SCIENCEJun 16 · 07:00 UTCSCIENTIFIC AMERICAN
    Jennifer Doudna

    Jennifer Doudna, a Nobel laureate, argues that the U.S. should treat scientific research as a critical component of national infrastructure. The article highlights her perspective on the importance of prioritizing scientific research for the country's development.

  • HEALTHMay 13 · 13:13 UTCSTAT NEWS
    STAT+: AI medical devices’ dirty FDA secret

    The article discusses AI medical devices and a secret related to the FDA. The author mentions an upcoming event, the STAT Breakthrough West Summit, and invites readers to meet up. The article is part of STAT's Health Tech newsletter.